04/15/2026
A two-year study reviewed the overall success of routine on-pump multivessel MICS CABG on 184 non-selected patients. The study shows safe, successful and satisfactory results even in obese, diabetic, low EF and COPD patients. As leaders in CVT surgery continue to prove minimally invasive CABG techniques are more beneficial to patient recovery and outcomes, surgeon's can look to the innovative portfolio from Delacroix-Chevalier to enable this skill set. Review the study and discover the quality and precision of the Delacroix-Chevalier MICS CABG instrument platform designed to empower your success at https://hubs.ly/Q04bZv9G0